End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
123 IDR | +6.03% | +18.27% | -89.26% |
05-10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
03-15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 715B 45.07M 60.81M | Sales 2023 | 702B 44.23M 59.68M | Capitalization | 613B 38.6M 52.08M |
---|---|---|---|---|---|
Net income 2022 | 275B 17.35M 23.42M | Net income 2023 | -85.22B -5.37M -7.24M | EV / Sales 2022 | 1.73 x |
Net Debt 2022 | 773B 48.73M 65.74M | Net Debt 2023 | 897B 56.51M 76.25M | EV / Sales 2023 | 2.15 x |
P/E ratio 2022 |
1.68
x | P/E ratio 2023 |
-7.19
x | Employees | 1,193 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.08% |
1 day | +6.03% | ||
1 week | +18.27% | ||
Current month | +19.42% | ||
1 month | +16.04% | ||
3 months | -83.60% | ||
6 months | -84.23% | ||
Current year | -89.26% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Gwan Lee
CEO | Chief Executive Officer | 61 | 20-08-13 |
Yenfrino Gunadi
DFI | Director of Finance/CFO | 38 | 20-08-13 |
Bedjo Stefanus
PRN | Corporate Officer/Principal | 60 | 23-06-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 15-05-24 | |
Robby Yulianto
CHM | Chairman | 42 | 20-08-13 |
Director/Board Member | 65 | 22-03-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 123 | +6.03% | 279,576,200 |
24-05-21 | 116 | +3.57% | 182,049,300 |
24-05-20 | 112 | +7.69% | 141,961,400 |
24-05-17 | 104 | -0.95% | 35,003,100 |
End-of-day quote INDONESIA S.E., May 21, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-89.26% | 86.42M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- PYFA Stock